> >
Phase III study

Phase III study

Multicenter studies in various populations of patients are carried out to prove drug efficacy and safety.


  • Development of phase III study protocols;

  • Development of supporting documents (protocol, investigator’s brochure, patient informed consent, paper and electronic CRF);

  • Selection of clinical bases for phase III studies;

  • Insurance of patients participating in phase III studies;

  • Obtaining approvals for a phase III study;

  • Arrangement, monitoring, data management and statistical processing of results of III phase studies;

  • Preparation of the final report on phase III studies;